Atlas Trials

Philidelphia Positive Chronic Myeloid Leukaemia

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Philidelphia Positive Chronic Myeloid Leukaemia

RecordFirmDate
Study to Assess Efficacy and Safety of Nilotinib 300mg Twice Daily in Patients With Philadelphia Positive Chronic Myeloid Leukaemia (CML) in Chronic Phase Who Are Intolerant to Prior Tyrosine Kinase Inhibitors. (NCT02108951)Novartis Pharmaceuticals2014-07-07

Track Philidelphia Positive Chronic Myeloid Leukaemia automatically

Every clearance here is in the API, with alerts when new ones post.